These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1825851)

  • 1. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
    Peleg L; Goldman B
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
    Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
    Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
    Prence EM; Natowicz MR; Zalewski I
    Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 4-methylumbelliferyl-6-sulpho-2-acetamido-2-deoxy-beta- D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villi.
    Grebner EE; Wenger DA
    Prenat Diagn; 1987 Jul; 7(6):419-23. PubMed ID: 2958791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
    Charrow J; Inui K; Wenger DA
    Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum hexosaminidase A in pregnancy: effects of gestational age and fetal genotype.
    Ben-Yoseph Y; Pack BA; Thomas PM; Nadler HL; Kaback MM
    Am J Med Genet; 1988 Apr; 29(4):891-9. PubMed ID: 2969680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal hexosaminidase A in mother's serum: pitfalls for carrier detection and prospects for prenatal diagnoses of GM2 gangliosidoses.
    Navon R; Lejbkowicz I; Adam A
    Am J Hum Genet; 1987 Jan; 40(1):60-1. PubMed ID: 2949607
    [No Abstract]   [Full Text] [Related]  

  • 14. First trimester prenatal diagnosis of Tay-Sachs disease using the sulfated synthetic substrate for hexosaminidase A.
    Callahan JW; Archibald A; Skomorowski MA; Shuman C; Clarke JT
    Clin Biochem; 1990 Dec; 23(6):533-6. PubMed ID: 2149678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
    Bayleran J; Hechtman P; Kolodny E; Kaback M
    Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay and heat denaturation enzyme assay for the detection of Tay-sachs heterozygotes during pregnancy.
    Nguyen C; Gold RJ; Mahuran D; Lowden JA
    Clin Chim Acta; 1981 Jun; 113(1):13-25. PubMed ID: 6453673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.